Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives Juniper Point2023-03-24T10:20:55+00:0003.02.2023| Read More
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023 Juniper Point2023-03-24T10:20:55+00:0002.23.2023| Read More
Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock Juniper Point2023-03-24T10:20:55+00:0002.10.2023| Read More
